5OWQ
Human STK10 bound to dovitinib
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04-1 |
Synchrotron site | Diamond |
Beamline | I04-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2012-02-18 |
Detector | DECTRIS PILATUS 2M |
Wavelength(s) | 0.9173 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 57.570, 50.400, 114.570 |
Unit cell angles | 90.00, 96.60, 90.00 |
Refinement procedure
Resolution | 57.190 - 2.700 |
R-factor | 0.26535 |
Rwork | 0.263 |
R-free | 0.30495 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | STK10 |
RMSD bond length | 0.014 |
RMSD bond angle | 1.693 |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0158) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 57.190 | 2.860 |
High resolution limit [Å] | 2.700 | 2.700 |
Rmerge | 0.140 | 0.610 |
Number of reflections | 16619 | 2672 |
<I/σ(I)> | 4.7 | 1.3 |
Completeness [%] | 91.4 | 91.8 |
Redundancy | 2.8 | 2.7 |
CC(1/2) | 0.984 | 0.692 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 277 | 0.1M sodium formate, 15%(w/v) PEG 3350 |